OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative study
Xuefen Lei, Yang Ke, Tianhao Bao, et al.
World Journal of Clinical Cases (2018) Vol. 6, Iss. 5, pp. 74-83
Open Access | Times Cited: 11
Xuefen Lei, Yang Ke, Tianhao Bao, et al.
World Journal of Clinical Cases (2018) Vol. 6, Iss. 5, pp. 74-83
Open Access | Times Cited: 11
Showing 11 citing articles:
Targeted therapy for hepatocellular carcinoma
Ao Huang, Xin–Rong Yang, Wen Yuan Chung, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 556
Ao Huang, Xin–Rong Yang, Wen Yuan Chung, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 556
Role of locoregional therapies in the wake of systemic therapy
Daniel H. Palmer, Katerina Malagari, Laura Kulik
Journal of Hepatology (2020) Vol. 72, Iss. 2, pp. 277-287
Open Access | Times Cited: 72
Daniel H. Palmer, Katerina Malagari, Laura Kulik
Journal of Hepatology (2020) Vol. 72, Iss. 2, pp. 277-287
Open Access | Times Cited: 72
Transarterial chemoembolization (TACE) plus tyrosine kinase inhibitors versus TACE in patients with hepatocellular carcinoma: a systematic review and meta-analysis
Ruihua Duan, Fen Gong, Yan Wang, et al.
World Journal of Surgical Oncology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 20
Ruihua Duan, Fen Gong, Yan Wang, et al.
World Journal of Surgical Oncology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 20
The combination therapy of transarterial chemoembolisation and sorafenib is the preferred palliative treatment for advanced hepatocellular carcinoma patients: a meta-analysis
Zhoujing Cheng, Lin He, Yingjie Guo, et al.
World Journal of Surgical Oncology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 21
Zhoujing Cheng, Lin He, Yingjie Guo, et al.
World Journal of Surgical Oncology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 21
Efficacy of Transarterial Chemoembolization Combined with Molecular Targeted Agents for Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis
Zhenzhen Zhang, Yanfang Wu, Tang‐Hui Zheng, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3710-3710
Open Access | Times Cited: 14
Zhenzhen Zhang, Yanfang Wu, Tang‐Hui Zheng, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3710-3710
Open Access | Times Cited: 14
Effectiveness of c-TACE Combined With Sorafenib Versus c-TACE Monotherapy in Advanced Hepatocellular Carcinoma: A Retrospective Study
Shanshan Liu, Yunwei Han, Zhihong Zhang, et al.
Clinical Medicine Insights Oncology (2023) Vol. 17
Open Access | Times Cited: 7
Shanshan Liu, Yunwei Han, Zhihong Zhang, et al.
Clinical Medicine Insights Oncology (2023) Vol. 17
Open Access | Times Cited: 7
Combination of NK-based immunotherapy and sorafenib against hepatocellular carcinoma.
Jia Yang, Aydιn Eresen, Alessandro Scotti, et al.
American Journal of Cancer Research (2021) Vol. 11, Iss. 2, pp. 337-349
Closed Access | Times Cited: 14
Jia Yang, Aydιn Eresen, Alessandro Scotti, et al.
American Journal of Cancer Research (2021) Vol. 11, Iss. 2, pp. 337-349
Closed Access | Times Cited: 14
Enhanced antitumour effect for hepatocellular carcinoma in the advanced stage using a cyclodextrin-sorafenib-chaperoned inclusion complex
Chi Uyen Phan, Ziyang Zheng, Jianwei Wang, et al.
Biomaterials Science (2019) Vol. 7, Iss. 11, pp. 4758-4768
Closed Access | Times Cited: 13
Chi Uyen Phan, Ziyang Zheng, Jianwei Wang, et al.
Biomaterials Science (2019) Vol. 7, Iss. 11, pp. 4758-4768
Closed Access | Times Cited: 13
Comparative efficacy and safety of molecular targeted agents combined with transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: a network meta-analysis
Jiaye Long, Baoxiang Chen, Zhaohui Liu
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Jiaye Long, Baoxiang Chen, Zhaohui Liu
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Trans-catheter arterial chemoembolization plus Sorafenib, an unsuccessful therapy in the treatment of hepatocellular carcinoma?
Tao Zhang, Weisen Huang, Haorong Dong, et al.
Medicine (2020) Vol. 99, Iss. 29, pp. e20962-e20962
Open Access | Times Cited: 6
Tao Zhang, Weisen Huang, Haorong Dong, et al.
Medicine (2020) Vol. 99, Iss. 29, pp. e20962-e20962
Open Access | Times Cited: 6
Response of human cancer cells to simultaneous treatment with sorafenib and radiofrequency current
María Luisa Hernández‐Bule, María A. Martínez, María Ángeles Trillo, et al.
Oncology Letters (2021) Vol. 22, Iss. 5
Open Access | Times Cited: 2
María Luisa Hernández‐Bule, María A. Martínez, María Ángeles Trillo, et al.
Oncology Letters (2021) Vol. 22, Iss. 5
Open Access | Times Cited: 2
